• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Patients offer reasons why they are not getting COVID-19 vaccine boosters


Survey examines slow uptake of vaccines among adults.

If your patients have been slow to get COVID-19 booster shots, here are some of the prevailing reasons why.

In a new study, researchers noted bivalent boosters were recommended for every aged 12 years and older since September 2022. That expanded to all people aged 6 months and older as of December last year.

But as of May 2023, fewer that 20% of eligible people had received updated boosters. That’s a “critical public health challenge,” said the study, “Understanding low COVID-19 booster uptake among US adults,” published in the journal Vaccine.

In February and March 2023, researchers led by the University of Arizona Cancer Center surveyed 2,196 adults who had received at least one dose of the COVID-19 vaccine.

The poll asked the question: “Have you received the updated (bivalent, omicron) mRNA booster from Pfizer or Moderna?”

Among them, 1,637, or 74.5%, had received the booster, but 559 did not. To explain why, participants could select one or multiple answers, or write in their own. Responses fell into three groups:

  • Knowledge about the bivalent vaccine
  • Risks or benefits were not clear
  • Logistic concerns

“Interventions to improve vaccination rates require a variety of approaches,” the study said. A good start is to consider the top reasons why some participants opted not to get their COVID-19 booster.

Related Videos
Michael J. Barry, MD
Kalvin Yu, MD
William Cooke, MD, FAAFP, FASAM, AAHIVS, gives expert advice
J. Corey Feist, JD, MBA, gives expert advice